Discover how next-generation lipid nanoparticles (LNPs) are revolutionizing Gene Editing by enabling safe, precise, and efficient delivery of CRISPR and RNA-based tools. Gene Editing is ready, and delivery is allowing translation Gene Editing has entered the golden era. Technologies like CRISPR-Cas9, base editors, and prime editors are [...]
Gene Editing has become one of the most promising areas in modern biotechnology, offering the potential to correct genetic mutations at their source. Tools like CRISPR/Cas9, base editors, and prime editing systems are opening new therapeutic frontiers in rare diseases, oncology, and regenerative medicine. However, the delivery of these gene editing [...]
DIVERSA Technologies is excited to announce our participation in several key partnering events in the coming months! As leaders in optimized formulations for drug delivery and biomolecules, these events provide an invaluable opportunity for us to connect with industry professionals and showcase our innovative solutions. [...]
The potential of non-viral lipid delivery systems for improving global health has been proven once again. From rare diseases to cancer, gene editing and gene therapies will undoubtedly benefit from the latest advances in nanomedicine. In February 2024, the results from a promising combined phase [...]
2024 is here full of new resolutions and challenges. And so, in an ever-evolving field such as medicine, it's inevitable to wonder what exciting advances the new year will bring. Nature medicine has asked leading researchers to discover what clinical trials may impact medicine in [...]
